Ducray, François
Memorial Sloan Kettering Cancer Center · Tel Aviv University · University of California, San Francisco · Rabin Medical Center · Sorbonne Université · Assistance Publique – Hôpitaux de Paris · Hospices Civils de Lyon · Hôpital Pierre Wertheimer · Centre de Recherche en Cancérologie de Lyon · Duke Medical Center · Erasmus MC Cancer Institute · Institut du Cerveau
7 papers on CoChatORCID 0000-0002-8150-5785
Most cited papers
- Verified
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Mellinghoff, I. K., van den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., et al. (2023) · New England Journal of Medicine
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 814
- Verified · note
Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma: A Plea for Systematic Measurement of Growth Rates
Pallud, J., Taillandier, L., Capelle, L., Fontaine, D., Peyre, M., Ducray, F., Duffau, H., & Mandonnet, E. (2012) · Neurosurgery
Glioma Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging
Cited by 135
- Verified
PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas
Appay, R., Dehais, C., Colin, C., Alentorn, A., Carpentier, C., Ducray, F., Ibdaih, A., Kamoun, A., Mokhtari, K., Tabouret, E., et al. (2019) · Neuro-Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 126
- Verified
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations
Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Forest, F., Maurage, C.-A., Vignaud, J.-M., et al. (2014) · Neuro-Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 63
- Verified
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells
Durand, S., Bruelle, M., Bourdelais, F., Bennychen, B., Blin-Gonthier, J., Isaac, C., Huyghe, A., Martel, S., Seyve, A., Vanbelle, C., et al. (2023) · Nature Communications
Pluripotent Stem Cells ResearchRNA and protein synthesis mechanisms
Cited by 21
- Verified
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells.
Durand, S., Bruelle, M., Bourdelais, F., Bennychen, B., Blin, J., Isaac, C., Huyghe, A., Seyve, A., Vanbelle, C., Meyronet, D., et al. (2022) · Nature Communications
Pluripotent Stem Cells ResearchRNA and protein synthesis mechanisms
Cited by 21
- Verified
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells
Durand, S., Bruelle, M., Bourdelais, F., Bennychen, B., Blin-Gonthier, J., Isaac, C., Huyghe, A., Seyve, A., Vanbelle, C., Meyronet, D., et al. (2021) · Nature Communications
Pluripotent Stem Cells ResearchRNA and protein synthesis mechanisms
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free